Hello, Guest!
  • Thursday, April 25, 2024

Eli Lilly Receives $625M Army Contract Modification for COVID-19 Antibody Therapy

Eli Lilly and Co. (NYSE: LLY) has secured a $625 million contract modification to supply 500,000 more doses of the company’s COVID-19 monoclonal antibody drug to the U.S. Army.

Army Contracting Command obligated the full amount of the modification using fiscal 2021 Coronavirus Aid, Relief and Economic Security Act funds, the Department of Defense said Wednesday.

In November, the Food and Drug Administration granted emergency use authorization for Lilly’s LY-CoV555 antibody drug as a treatment for patients 12 years and older who have mild to moderate COVID-19 and at risk of developing severe coronavirus infection.

Bamlanivimab is intended to be administered via intravenous infusion, the company noted.

Video of the Day

Related Articles

Northrop Lands $167M Navy Contract Modification for G/ATOR Radar Tech Contract Awards

Northrop Lands $167M Navy Contract Modification for G/ATOR Radar Tech

Northrop Grumman (NYSE: NOC) has secured a potential $167.1 million contract modification from the U.S. Navy to supply four lot 6 full-rate production Ground/Air Task Oriented Radar systems. Marine Corps Systems Command is the contracting activity and will obligate the full contract amount using the U.S. Air Force’s other procurement funds for fiscal year 2024,

HII to Create Quality-of-Service Incentive Program for USS Enterprise Builders Contract Awards

HII to Create Quality-of-Service Incentive Program for USS Enterprise Builders

HII (NYSE: HII) has received a $120.3 million contract modification from the U.S. Navy to create a special incentive program to improve the quality of life for sailors stationed at the company’s facility in Newport News, Virginia. The modification was made under a previously awarded contract for the design and construction of the future USS

Navy Unveils $250M Award to UW’s Applied Physics Lab for DOD R&D Support Contract Awards

Navy Unveils $250M Award to UW’s Applied Physics Lab for DOD R&D Support

The U.S. Navy has awarded a potential $250 million contract modification to the University of Washington’s Applied Physics Laboratory to sustain its provision of research, development, test and evaluation support for Department of Defense programs. The modification raises the ceiling value of a previously awarded contract to $925.8 million, the Department of Defense said Friday. In October